GLP-1 drugs such as Ozempic and Wegovy boost weight loss and heart health, but experts warn of nausea, dehydration, and…
FDA warns of growing risks from gray-market GLP-1 drugs as unregulated Ozempic and Wegovy alternatives raise safety and counterfeit concerns.
GLP-1 drugs show promise in lowering cancer risks for women, while also improving obesity, fertility, and overall health outcomes.
Sign in to your account
Remember me